HOME / PUBLICATIONS /

SAT-300 The effect of antiviral therapy on the outcomes of baseline grey-zone (GZ) patients with HBeAg-negative chronic hepatitis B virus infection (CHBVe-)

Citation:

Papatheodoridi M, Paraskevopoulou S, Ioannidou P, Fytili P, Karagiannakis D, Cholongitas E, Vlachogiannakos I, Papatheodoridis G. SAT-300 The effect of antiviral therapy on the outcomes of baseline grey-zone (GZ) patients with HBeAg-negative chronic hepatitis B virus infection (CHBVe-). Journal of Hepatology. 2025;82:S800. Copy at http://www.tinyurl.com/ymurca6l